retatrutide moa Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide and its potential benefits.

A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes

Anna Bartter is a freelance journalist who writes about health, fitness and women's lifestyle for publications including Women's Health, Stylist, The iPaper, Metro and Psychologies, among others

Functional nutrition brands are leaning into direct-to-consumer education and higher-margin complete nutrition formats

ESC guidelines for the management of cardiovascular disease in patients with diabetes

Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK